在膜心脏病中优化抗凝血:导航NOAC和VKA
Anca Ouatu1,2, Oana Nicoleta Buliga-Finiș1,2, Daniela Maria Tanase1,2
1Faculty of General Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.
Journal of personalized medicine
|September 28, 2024
概括
非维生素K对抗剂口服抗凝剂 (NOACs) 对心房动和膜心脏病患者显示有前途. 目前正在进行研究,以确定NOAC在各种门条件下的特定用途.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 非维生素K对抗剂口服抗凝剂 (NOACs) 对非膜动 (AF) 的维生素K对抗剂 (VKAs) 具有优势.
- NOACs具有有利的药理特性,如快速开始/抵消和固定的剂量,减少监测需求.
- 在AF和膜心脏病 (VHD) 患者中调查NOAC是一个不断增长的研究领域.
研究的目的:
- 审查和确定在患有VHD的患者处方NOAC的特定临床场景.
- 专注于NOAC在不同类型的门病变中的应用.
主要方法:
- 现有临床试验的分析,不包括特定的VHD患者群体 (机械门,中度/重度关狭窄症).
- 对正在进行的随机对照试验 (RCT) 进行审查,调查中度至重度类风湿性额头狭窄症的NOAC.
- 评估最近关于NOAC在患有AF和生物假体或透导心脏门的患者中使用的试验数据.
主要成果:
- 之前的试验表明,NOAC在某些VHD人群中比VKA更有好处,但不包括机械门和严重的额头缩.
- 最近的研究表明,NOAC在患有AF和生物假体或透管心脏门的患者中的安全性.
- 目前正在进行的RCT的目的是为中度至重度的类风湿性关节狭窄症中NOACs提供最终证据.
结论:
- 需要进一步的研究来确定NOAC在机械假体门患者的疗效和安全性.
- 确定各种VHD类型的NOACs的精确指示,包括额头肌狭窄症和机械,至关重要.
- 目前的证据支持NOAC在特定VHD亚组中的使用,目前正在进行的研究扩大了这一理解.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:29Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
01:26Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
01:30Venous Thrombosis IV: Nursing Management
3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3